Potential limitations of transcription terminators used as transgene insulators in adenoviral vectors
Open Access
- 1 February 2002
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (3) , 227-231
- https://doi.org/10.1038/sj.gt.3301640
Abstract
The presence of adenoviral cis-elements interfering with the activity of tissue-specific promoters has seriously impaired the use of transcriptional targeting adenoviruses for gene therapy purposes. As an approach to overcome this limitation, transcription terminators were previously employed in cultured cells to insulate a transgene promoter from viral activation. To extend these studies in vivo, we have injected into heart and skeletal muscle, adenoviruses containing the human growth hormone terminator and the cardiac-specific α-myosin heavy chain promoter (αMyHC) driving the chloramphenicol acetyltransferase (CAT) reporter gene. Promoterless CAT constructs were also tested to study interfering viral transcription and terminator activity. Here we demonstrate that the presence of a terminator can produce undesirable effects on the activity of heterologous promoters. Our analysis shows that in particular conditions, a terminator can reduce the tissue specificity of the transgene promoter. By RNAse protection assay performed on cardiac myocytes, we also show that adenoviral elements can direct high levels of autonomous transcription within the E1A enhancer region. This finding supports the model that passive readthrough of the transgene promoter is responsible for loss of selective expression.Keywords
This publication has 17 references indexed in Scilit:
- Considerations and challenges for the achievement of targeted gene deliveryGene Therapy, 1999
- Heart-Specific Targeting ofβ-Galactosidase by the Ventricle-Specific Cardiac Myosin Light Chain 2 Promoter Using Adenovirus VectorsHuman Gene Therapy, 1998
- Cell-specific promoter in adenovirus vector for transgenic expression of SERCA1 ATPase in cardiac myocytesAmerican Journal of Physiology-Cell Physiology, 1998
- Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzymeGene Therapy, 1997
- Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.Journal of Clinical Investigation, 1997
- Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancerGene Therapy, 1997
- Modulation of the Specificity and Activity of a Cellular Promoter in an Adenoviral VectorHuman Gene Therapy, 1997
- Redundant elements in the adenovirus type 5 inverted terminal repeat promote bidirectional transcriptionin Vitro and are important for virus growthin VivoVirology, 1991
- The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer elementCell, 1983
- Far upstream sequences are required for efficient transcription from the adenovirus-2 E1A transcription unitNucleic Acids Research, 1983